The £3,000 Capital Gains Allowance Window That's Closing Fast
UK investors have until 5 April 2026 to execute one of the most powerful yet underutilised tax strategies available to retail portfolios: the bed-and-ISA manoeuvre. With markets having delivered a turbulent first quarter — the FTSE 100 down 8.2% since January and tech stocks off 15% — millions of investors are sitting on paper losses that could be transformed into immediate tax relief.
The strategy is deceptively simple: sell losing positions in a General Investment Account (GIA) to crystallise the loss against your £3,000 annual Capital Gains Tax allowance, then immediately repurchase the same assets inside your ISA wrapper. Future gains are then protected from tax indefinitely.
Yet according to platform data from Hargreaves Lansdown and Interactive Investor, fewer than 12% of eligible investors actually execute this strategy each tax year — leaving potentially thousands of pounds in tax relief unclaimed.
How Bed-and-ISA Actually Works in Practice
The mechanics are straightforward, but the timing is critical. You must sell your losing positions in your GIA before midnight on 5 April 2026, crystallising the capital loss. You can then repurchase identical assets inside your ISA wrapper either the same day or any time after.
There's no 30-day rule for bed-and-ISA transactions — unlike bed-and-breakfast strategies where you must wait before repurchasing. The key requirement is that the repurchase happens inside a different account wrapper.
For a practical example: if you bought £10,000 of Vanguard FTSE Developed World UCITS ETF (VEVE) in your GIA last year and it's now worth £8,500, selling generates a £1,500 crystallised loss. You can immediately buy £8,500 worth of the same ETF inside your 2025-26 ISA allowance, protecting all future growth from tax.
Photo: Vanguard FTSE Developed World UCITS ETF, via fatfire.com
Platform Execution: Same-Day Settlements and Timing
Not all platforms handle bed-and-ISA transactions equally. Interactive Investor, AJ Bell Youinvest, and Hargreaves Lansdown all support same-day execution, allowing you to sell in your GIA and buy in your ISA within hours.
Trading 212 requires manual coordination — you must sell in your Invest account and separately purchase in your ISA account. Freetrade's basic tier doesn't support ISAs, forcing users to upgrade to Freetrade Plus (£9.99 monthly) to execute the strategy.
Vanguard UK's platform only allows direct ISA investments, so existing GIA holders must transfer funds to execute bed-and-ISA strategies elsewhere.
The critical timing window is narrow. Platform settlements typically take 2-3 business days, meaning investors need to initiate sales by 2 April to ensure completion before the tax year ends.
The £20,000 ISA Allowance Calculation
Executing bed-and-ISA strategies requires careful allowance management. Your 2025-26 ISA allowance is £20,000 total, and any repurchases count against this limit at current market value.
Using our earlier example, repurchasing £8,500 of VEVE inside your ISA consumes £8,500 of allowance, leaving £11,500 for additional investments before 5 April.
Crucially, you're only using your ISA allowance for the reduced current value, not the original purchase price. This makes bed-and-ISA particularly powerful in down markets — you can move more assets into tax protection for the same allowance cost.
Which Assets Make the Best Candidates
The strategy works best for liquid, easily tradeable assets. FTSE 100 stocks, major ETFs, and popular investment trusts all qualify. Unit trusts can be more complex due to pricing windows and settlement times.
Assets showing the largest losses offer the greatest tax benefit. Based on Q1 2026 performance, technology stocks, emerging market funds, and growth-focused investment trusts are prime candidates.
Avoid assets with wide bid-ask spreads or low liquidity — the transaction costs can erode the tax benefits. AIM stocks and niche sector funds often fall into this category.
The Inheritance Tax Shield Bonus
Beyond immediate CGT relief, bed-and-ISA strategies create long-term Inheritance Tax benefits. Assets inside ISA wrappers pass to spouses tax-free and can be inherited by other beneficiaries outside the £325,000 nil-rate band.
For investors with portfolios approaching IHT thresholds, moving assets into ISA protection through bed-and-ISA can be worth 40% in avoided future tax — potentially tens of thousands of pounds for larger portfolios.
Transaction Costs vs Tax Benefits
Platform dealing charges can impact the strategy's effectiveness. At £11.95 per transaction (typical for full-service platforms), bed-and-ISA only makes sense for losses exceeding £600-£800.
Fixed-fee platforms like Interactive Investor (£9.99 monthly, unlimited trades) make the strategy cost-effective for any meaningful loss. Trading 212's zero-commission model eliminates this concern entirely.
Always calculate the net benefit: (crystallised loss × your CGT rate) minus total transaction costs. For basic-rate taxpayers, this means losses above £1,200 typically justify the strategy. Higher-rate taxpayers need smaller losses to break even.
The 72-Hour Execution Checklist
With the tax year ending, time is critical. First, identify losing positions in your GIA worth crystallising. Calculate available ISA allowance for repurchases. Check your platform's settlement timeframes and dealing windows.
Initiate sales by 2 April to ensure completion before the deadline. Confirm ISA allowance availability before placing repurchase orders. Keep detailed records for your 2026-27 Self Assessment return.
Monitor market movements between sale and repurchase — volatile assets can move significantly even within hours.
What Changes After 6 April 2026
The new tax year brings fresh allowances but different opportunities. Your 2026-27 CGT allowance resets to £3,000, and you receive a new £20,000 ISA allowance.
However, any losses crystallised after 5 April count against next year's allowances, potentially reducing flexibility for future tax planning.
This article is for informational purposes only and does not constitute financial advice. Your capital is at risk. Past performance is not a reliable indicator of future results.